View in EDS PDF Full Text

Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.

Saved in:
Bibliographic Details
Title: Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
Authors: Takakura, M.1, Nakamura, M.1, Kyo, S.1 satoruky@med.kanazawa-u.ac.jp, Hashimoto, M.1, Mori, N.1, Ikoma, T.1, Mizumoto, Y.1, Fujiwara, T.2, Urata, Y.3, Inoue, M.1
Source: Cancer Gene Therapy. Jan2010, Vol. 17 Issue 1, p11-19. 9p. 1 Diagram, 5 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09291903
DOI:10.1038/cgt.2009.44